new IV antibiotic for methicillin-resistant Staph aureus (MRSA) infections, Vibativ (vy-BA-tiv)
November 2009
Please see the June 2013 FDA release regarding the expanded use of Vibativ
It's the first in a new class. But it's related to vancomycin...and has many of vanco's drawbacks.
Vibativ (telavancin) is only approved for complicated skin and skin structure infections in adults. It covers gram-positive bacteria, including MRSA.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote